Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1989 Aug;60(2):227–230. doi: 10.1038/bjc.1989.257

Changing patterns of relapse in Hodgkin's disease.

G Duchesne 1, J Crow 1, S Ashley 1, M Brada 1, A Horwich 1
PMCID: PMC2247024  PMID: 2765370

Abstract

The patterns of early and late relapses (those occurring later than 3 years after diagnosis) in 432 patients achieving complete remission after treatment for stage I and II Hodgkin's disease at the Royal Marsden Hospital between 1964 and 1983 were studied to identify factors predicting for late relapse. The incidence of early relapse has fallen progressively in recent treatment eras as staging procedures and management have improved but in contrast there has been no decrease in the risk of late relapse. The incidence of late relapse was greater in patients treated with radiotherapy rather than combined modality therapy (P less than 0.05). However, patients who were clinically staged and treated with combined modality therapy retained as high a risk of relapse between 3 and 6 years as in years 2 and 3. The risk of late relapse was also greater in patients with stage II disease and in those without B symptoms at presentation. Patients falling into the higher risk categories for late relapse require continued close follow-up beyond 3 years to monitor for possible relapse.

Full text

PDF
227

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Axtell L. M., Myers M. H., Thomas L. H., Berard C. W., Kagan A. R., Newell G. R. Prognostic indicators in Hodgkin's disease. Cancer. 1972 Jun;29(6):1481–1488. doi: 10.1002/1097-0142(197206)29:6<1481::aid-cncr2820290611>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  2. Brada M., Easton D. F., Horwich A., Peckham M. J. Clinical presentation as a predictor of laparotomy findings in supradiaphragmatic stage I and II Hodgkin's disease. Radiother Oncol. 1986 Jan;5(1):15–22. doi: 10.1016/s0167-8140(86)80004-4. [DOI] [PubMed] [Google Scholar]
  3. DeVita V. T., Jr, Simon R. M., Hubbard S. M., Young R. C., Berard C. W., Moxley J. H., 3rd, Frei E., 3rd, Carbone P. P., Canellos G. P. Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute. Ann Intern Med. 1980 May;92(5):587–595. doi: 10.7326/0003-4819-92-5-587. [DOI] [PubMed] [Google Scholar]
  4. Haybittle J. L., Hayhoe F. G., Easterling M. J., Jelliffe A. M., Bennett M. H., Vaughan Hudson G., Vaughan Hudson B., MacLennan K. A. Review of British National Lymphoma Investigation studies of Hodgkin's disease and development of prognostic index. Lancet. 1985 Apr 27;1(8435):967–972. doi: 10.1016/s0140-6736(85)91736-2. [DOI] [PubMed] [Google Scholar]
  5. Herman T. S., Hoppe R. T., Donaldson S. S., Cox R. S., Rosenberg S. A., Kaplan H. S. Late relapse among patients treated for Hodgkin's disease. Ann Intern Med. 1985 Mar;102(3):292–297. doi: 10.7326/0003-4819-102-3-292. [DOI] [PubMed] [Google Scholar]
  6. Hoppe R. T., Coleman C. N., Cox R. S., Rosenberg S. A., Kaplan H. S. The management of stage I--II Hodgkin's disease with irradiation alone or combined modality therapy: the Stanford experience. Blood. 1982 Mar;59(3):455–465. [PubMed] [Google Scholar]
  7. Horwich A., Easton D., Nogueira-Costa R., Liew K. H., Colman M., Peckham M. J. An analysis of prognostic factors in early stage Hodgkin's disease. Radiother Oncol. 1986 Oct;7(2):95–106. doi: 10.1016/s0167-8140(86)80089-5. [DOI] [PubMed] [Google Scholar]
  8. Kaye S. B., Juttner C. A., Smith I. E., Barrett A., Austin D. E., Peckham M. J., McElwain T. J. Three years' experience with Ch1VPP (a combination of drugs of low toxicity) for the treatment of Hodgkin's disease. Br J Cancer. 1979 Feb;39(2):168–174. doi: 10.1038/bjc.1979.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Sutcliffe S. B., Gospodarowicz M. K., Bergsagel D. E., Bush R. S., Alison R. E., Bean H. A., Brown T. C., Chua T., Clark R. M., Curtis J. E. Prognostic groups for management of localized Hodgkin's disease. J Clin Oncol. 1985 Mar;3(3):393–401. doi: 10.1200/JCO.1985.3.3.393. [DOI] [PubMed] [Google Scholar]
  10. Tubiana M., Henry-Amar M., Hayat M., Burgers M., Qasim M., Somers R., Sizoo W., van der Schueren E. The EORTC treatment of early stages of Hodgkin's disease: the role of radiotherapy. Int J Radiat Oncol Biol Phys. 1984 Feb;10(2):197–210. doi: 10.1016/0360-3016(84)90004-x. [DOI] [PubMed] [Google Scholar]
  11. Weller S. A., Glatstein E., Kaplan H. S., Rosenberg S. A. Initial relapses in previously treated Hodgkin's disease. I. Results of second treatment. Cancer. 1976 Jun;37(6):2840–2846. doi: 10.1002/1097-0142(197606)37:6<2840::aid-cncr2820370640>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  12. Yarnold J. R., Jelliffe A. M., Hudson G. V. Patterns of relapse following radiotherapy for Hodgkin's disease. Clin Radiol. 1982 Mar;33(2):137–140. doi: 10.1016/s0009-9260(82)80037-8. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES